Abstract Background and Objective The Australian National COVID-19 Clinical Evidence
Taskforce is developing living, evidence-based, national guidelines for treatment of people …

Abstract Objectives The Australian National COVID-19 Clinical Evidence Taskforce has
been developing, maintaining, and disseminating living guidelines and decision support …

Introduction The Australian National COVID-19 Clinical Evidence Taskforce is producing
living, evidence-based, national guidelines for treatment of people with COVID-19 which are …

Abstract Background and Objectives The Australian National COVID-19 Clinical Evidence
Taskforce is a consortium of 31 Australian health professional organisations developing …

Objectives To investigate how quickly evidence was incorporated into the Australian living
guidelines for COVID-19 during the first 12 months of the pandemic. Study Design and …

Abstract Introduction The Australian National COVID‐19 Clinical Evidence Taskforce was
established in March 2020 to maintain up‐to‐date recommendations for the treatment of …

There is little understanding about what proportion of the target audience have read
guidelines published through the traditional approach. The COVID-19 pandemic created a …

Introduction Living guidelines provide reliable, ongoing evidence surveillance and regularly
updated recommendations for healthcare decision-making. As a relatively new concept …

What is new? Key findings: Despite clear scope, most guidelines for SARS CoV-2 infections
and for other care in the context of COVID-19 fell short of basic methodological standards …

Objective To appraise the availability, quality, and inclusivity of clinical guidelines produced
in the early stage of the coronavirus disease 2019 (covid-19) pandemic. Design Rapid …